The panel also had concerns that the risk of ARIA ... i.e. they have two copies of the variant – as they would be "more likely to become eligible for treatment with Leqembi." ...

it could also help offset concerns that the rate of ARIA-E and ARIA-H are a little higher with Kisunla than with Leqembi. The company said it plans to submit the TRAILBLAZER-ALZ 6 data to ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

The year 2030 is fast approaching, marking a significant shift in environmental sustainability within EU member states. Yet, ...

Key contributors included LEQEMBI with a 28.1 billion yen increase, Lenvima with 24.9 billion yen growth, and Dayvigo up by 9.3 billion yen. Naito emphasized significant milestones for LEQEMBI ...

Investing.com -- Shares of BioArctic AB (STO:BIOA B) climbed 4.8% following the announcement of its partner Eisai's robust sales figures for Leqembi, which exceeded consensus estimates.

Their doctor places them both on Leqembi, recently approved by the FDA for use in men and women with early-stage Alzheimer’s. The husband has a positive cognitive response to Leqembi ...

Wicked’s Cynthia Erivo detailed the special moment she shared with Taylor Swift at the 2025 Grammys in an exclusive interview with E! News at the Critics Choice Awards Feb. 7. Adam Brody and ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease. “The approval of once every four-week ...

Eisai’s Biogen-partnered Alzheimer’s therapy Leqembi is “on track” to meet a fiscal year 2024 revenue goal of ¥42.5 billion ($279 million)—despite U.S. sales continuing to drag. In the third quarter ...

Investing.com -- Shares of BioArctic AB (STO:BIOA B) climbed 4.8% following the announcement of its partner Eisai's robust sales figures for Leqembi, which exceeded consensus estimates. The ...